Profil bibliographique

Eiji Takeuchi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

388Publications signalées

4508Citations signalées

1Affiliations récentes

Institutions déclarées

National Hospital Organization Kochi National Hospital

Domaines associés

Aortic Disease and Treatment ApproachesCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentCardiac Valve Diseases and TreatmentsLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2026 articleOpenAlex

Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two‐Center Retrospective Study

Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano et autres

0 citationsThoracic Cancer

Accès ouvert 2026 articleOpenAlex

Incidence of RSV‐ and Influenza‐Associated Hospitalizations With Community‐Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan in 2022–2024: APSG‐J2 Study

Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel, Y. Fujita et autres

0 citationsInfluenza and Other Respiratory Viruses

2025 articleOpenAlex

MO47-5 An increased relative eosinophil count as a predictive dynamic biomarker in NSCLC patients treated with ICIs

Eiji Takeuchi

0 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature review

Yugo Matsumura, Seiya Ichihara, Kaori Nii, Naoki Kadota et autres

2 citationsMedicine

Accès ouvert 2025 articleOpenAlex

First‐Line Osimertinib for EGFR‐Mutated Squamous Cell Lung Carcinoma: A Case Report

Yugo Matsumura, Seiya Ichihara, Kaori Nii, Kazumasa Nanjo et autres

0 citationsCancer Reports

Accès ouvert 2025 preprintOpenAlex

Estimating Incidence of Respiratory Syncytial Virus- and Influenza Virus-Associated Hospitalizations with Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan During and After the COVID-19 Era: A Multicenter Active Surveillance Study (APSG-J2)

Haruka Maeda, Shingo Masuda, Bhim Gopal Dhoubhadel, Yuka Fujita et autres

2 citationsmedRxiv

Accès ouvert 2025 articleOpenAlex

Pulmonary cavitary disease due to Mycobacterium intracellulare cured in a healthy young adult leaving only calcifications

Hiroki Takahashi, Yuko Toyoda, Eiji Takeuchi, Tsutomu Shinohara

0 citationsInternational Journal of Infectious Diseases

Accès ouvert 2024 articleOpenAlex

Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report

Yugo Matsumura, Seiya Ichihara, Kaori Nii, Kazumasa Nanjo et autres

3 citationsThoracic Cancer

Accès ouvert 2024 articleOpenAlex

EP.13D.04 The Conflicting Impacts of G-CSF on the Therapeutic Efficacy of Chemoimmunotherapy for Extensive Stage Small Cell Lung Cancer

Yuji Tsukazaki, Hirokazu Ogino, Yoshio Okano, Satsuki Kakiuchi et autres

1 citationJournal of Thoracic Oncology

Accès ouvert 2024 articleOpenAlex

MO10-4 Pretreatment eosinophil counts as a predictive biomarker in NSCLC patients treated with immune checkpoint inhibitors

Eiji Takeuchi, Keiichi Kondo, Yasuko Okano, Shigeyasu Ichihara et autres

0 citationsAnnals of Oncology

2024 articleOpenAlex

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer

Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi et autres

8 citationsInternational Journal of Clinical Oncology

Accès ouvert 2023 articleOpenAlex

An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano et autres

15 citationsThoracic Cancer

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.